Certolizumab pegol in the treatment of rheumatoid arthritis: a comprehensive review of its clinical efficacy and safety.
about
Regulation of tumour necrosis factor signalling: live or let diePotential applications and human biosafety of nanomaterials used in nanomedicineNovel Human Three-Domain Antibody Fragments Against sTNFα as Well as tmTNFα with High Affinity Generated by the Combination of Ribosome Display and E. coli Expression System.Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targetsCertolizumab pegol for the treatment of rheumatoid arthritis.PEGylated therapeutic proteins for haemophilia treatment: a review for haemophilia caregivers.Therapeutic nanoparticles in clinics and under clinical evaluation.Two-year radiographic and clinical outcomes from the Canadian Methotrexate and Etanercept Outcome study in patients with rheumatoid arthritis.Methotrexate: optimizing the efficacy in rheumatoid arthritis.Acute exacerbation of rheumatoid interstitial lung disease during the maintenance therapy with certolizumab pegol.DNA methylation as a marker of response in rheumatoid arthritis.
P2860
Q28262381-B233E88C-6D62-4589-8C27-D7D4C6EB21FDQ32944368-D7A0FD76-9374-44A4-AD82-7B5103D21960Q35918691-24BF4165-9C6F-48A7-BE11-3C212443B6B2Q36158922-9B4D4C2E-7420-4AA1-B305-FB3394A6EC04Q37967946-06D1CB1C-89C7-4587-B335-40B428FE3365Q38036746-DFCCEA8B-967A-4E4C-B348-6C41C9B3457EQ38087986-1DFAD3EF-80DF-4E23-B5DE-3C7132392EE8Q40548376-FC1F64AA-8044-4AD1-BA52-1EA5DD2D4187Q42117581-F6A85EC8-3DCF-45A9-90FC-0A1DD4F5417AQ51625080-87674B04-9219-47AF-ABCF-7ECA1D724998Q52536411-3B33E9B5-B5EB-4C3B-82C3-29074C7810A4
P2860
Certolizumab pegol in the treatment of rheumatoid arthritis: a comprehensive review of its clinical efficacy and safety.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Certolizumab pegol in the trea ...... clinical efficacy and safety.
@ast
Certolizumab pegol in the trea ...... clinical efficacy and safety.
@en
Certolizumab pegol in the trea ...... clinical efficacy and safety.
@nl
type
label
Certolizumab pegol in the trea ...... clinical efficacy and safety.
@ast
Certolizumab pegol in the trea ...... clinical efficacy and safety.
@en
Certolizumab pegol in the trea ...... clinical efficacy and safety.
@nl
prefLabel
Certolizumab pegol in the trea ...... clinical efficacy and safety.
@ast
Certolizumab pegol in the trea ...... clinical efficacy and safety.
@en
Certolizumab pegol in the trea ...... clinical efficacy and safety.
@nl
P2860
P921
P356
P1433
P1476
Certolizumab pegol in the trea ...... clinical efficacy and safety.
@en
P2093
Philip J Mease
P275
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEQ285
P5008
P577
2010-09-25T00:00:00Z
2011-02-01T00:00:00Z